Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION USP

Last updated on 2021-03-29 History
Report ID 116929
Drug Identification Number 02239944
Brand name KETOROLAC TROMETHAMINE INJECTION USP
Common or Proper name KETOROLAC TROMETHAMINE INJECTION USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) KETOROLAC TROMETHAMINE
Strength(s) 30MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 ML
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-06-05
Estimated end date 2021-04-23
Actual end date 2021-03-26
Shortage status Resolved
Updated date 2021-03-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-03-29 French Compare
v7 2021-03-29 English Compare
v6 2021-03-22 French Compare
v5 2021-03-22 English Compare
v4 2020-09-21 French Compare
v3 2020-09-21 English Compare
v2 2020-06-08 French Compare
v1 2020-06-08 English Compare

Showing 1 to 8 of 8